Recall Record

Indianapolis, IN, United States

Roche Diagnostics Operations, Inc. recalls

33 recalls recorded since 2018, most recently on 20 January 2026. 11 are listed as ongoing. Status and classification are as published by the FDA.

Recalls33
Ongoing (FDA)11
Terminated or completed22
Class I (FDA)0

Ongoing Class II Medical devices

Recall started
20 January 2026
Reason
Software defect, which allows the system to accept erroneous, non-monotonous calibrations for Spline-type assays. Cobas pro integrated solutions is an automated analyzer, intended for running qualitative, semi-quantitative and quantitative clinical chemistry and immunochemistry assays, as well as ion-selective measurements. When an erroneous calibration is active, the instrument fails to calculate new values and instead repeats the last successfully calculated result from any Spline-type assay for all subsequent measurements, leading to identical and erroneous patient and QC results. The defect could lead to patients receiving erroneous lab results, which could result in a remote risk of serious adverse health consequences. The following assays use spline type calibration and are affected by this issue: Cystatin C Gen.2, Ferritin Gen.4, Lipoprotein (a) Gen. 2, Lipoprotein (a) molarity, Vancomycin Gen.3, Kappa Free Light Chains Partner Channel, Lambda Free Light Chains Partner Channel, and fCAL turbo Partner Channel.
Distribution
US Nationwide distribution.
Initiated
Voluntary: Firm initiated
Recall number
Z-1476-2026

Ongoing Class II Medical devices

Recall started
21 November 2025
Reason
Issues identified: 1) Results vary by Instrument Platform; 2) Calibrator Lot-to-Lot Variability. Issues may lead to delayed or incorrect diagnosis, as well as delay of treatment or incorrect treatment.
Distribution
US Nationwide distribution in the states of AZ, CA, FL, GA, IL, IN, ME, MI, MN, NC, NJ, NM, NY, OH, PA, PR, TN, TX, UT, WA, WV.
Initiated
Voluntary: Firm initiated
Recall number
Z-1009-2026

Ongoing Class II Medical devices

Recall started
17 October 2024
Reason
Abnormal calibration signals and control recovery issues on the Homocysteine Enzymatic (HCYS) Assay can produce erroneous patient results (positive or negative bias)
Distribution
US: NJ, TX, NY, FL, IN, TX, OK, SC, IA,
Initiated
Voluntary: Firm initiated
Recall number
Z-0489-2025

Ongoing Class II Medical devices

Recall started
15 August 2024
Reason
Creatine Kinase (CK) Assay Abnormal calibrations on the cobas¿ c 311/501/502 and COBAS INTEGRA 400 plus Analyzers may lead to erroneous results and misdiagnosis.
Distribution
US Nationwide distribution.
Initiated
Voluntary: Firm initiated
Recall number
Z-3187-2024

Ongoing Class II Medical devices

Recall started
3 October 2023
Reason
Elevated results were detected with Li-heparin plasma samples when compared to citrated plasma samples.
Distribution
US Nationwide distribution.
Initiated
Voluntary: Firm initiated
Recall number
Z-0352-2024

Ongoing Class II Medical devices

Recall started
12 December 2022
Reason
A complaint investigation revealed that an incorrect behavior relating to the rejection of orders capability of the Host Connectivity Agent (HCA) could occur where the order received from the Laboratory Information System (LIS) is created with an Internal ID rather than the External ID sent from the LIS. The erroneous event occurs under rare circumstances where the date in the sample's barcode does not match the order date sent from the LIS, and can lead to the order being mismatched to an another patient's sample ID rather than the subject patient's sample ID. The software bug impacts multiple cobas infinity central lab software (versions 2.5.x , 3.01.x, 3.02.x, and 3.03.x) and occurs when the afflicted software has been configured with specific pre-conditions.
Distribution
Domestic distribution nationwide. Foreign distribution pending.
Initiated
Voluntary: Firm initiated
Recall number
Z-0952-2023

Ongoing Class II Medical devices

Recall started
14 July 2022
Reason
Software issue resulting in signals and sample test results of Pre-Wash tests being impacted. The following assays are considered impacted by the issue: Anti-HAV2, Anti-HBc IgM, IGF-1, Myogloin, Rubella IgG, and Toxo IgG.
Distribution
US Nationwide distribution including in the states of AK, AL, AR, AZ, CA, CO, CT, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, NH, NJ, NM, NV, NY, OH, OK, OR, PA, RI, SC, TN, TX, UT, VA, WA, WI, WV, WY, DC & PR.
Initiated
Voluntary: Firm initiated
Recall number
Z-1515-2022

Terminated Class II Medical devices

Recall started
18 October 2021
Terminated
31 May 2023
Reason
A potential risk for false negative nitrite results exists when endogenous creatinine levels are 15,000 mg/L and above. No interference of Nitrite results was observed at creatinine levels up to 9,000 mg/L.
Distribution
US Nationwide distribution.
Initiated
Voluntary: Firm initiated
Recall number
Z-0266-2022

Terminated Class II Medical devices

Recall started
24 June 2021
Terminated
21 July 2023
Reason
Under specific circumstances created by the user, the cobas e flow test results could be replaced by an automatic result sent to the lab LIS. This automatic result could be released and interpreted by your Laboratory Information System (LIS) as a false positive or negative result. It should be noted that the "correct" result would still be available on the instrument.
Distribution
US Nationwide distribution
Initiated
Voluntary: Firm initiated
Recall number
Z-2444-2021

Ongoing Class II Medical devices

Recall started
26 April 2021
Reason
Roche received several complaints regarding increased control recovery and discrepant elevated results for the Iron Gen.2 (IRON2) assay on the cobas c311, 501, and 502 analyzers and on the COBAS Integra 400 plus analyzer.
Distribution
US Nationwide distribution in the states of AK, AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, GU, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, PR, RI, SC, SD, TN, TX, UT, VA, VT, WA, WI, WV, WY.
Initiated
Voluntary: Firm initiated
Recall number
Z-1675-2021

Ongoing Class II Medical devices

Recall started
7 April 2021
Reason
Recall reason is possible sporadic false negative conventional troponin results. Roche has confirmed an issue with running Elecsys Troponin I/Troponin I STAT and Elecsys proBNP II/proBNP II STAT on the cobas e 601 and 602 modules. When the proBNP II analyte is measured immediately before the Troponin I analyte on the same module, a decreased recovery on Troponin I was observed.
Distribution
US Nationwide distribution in the states of AL, AZ, CA, CT, FL, GA, ID, IL, IN,KS, KY, MD, ME, MO, NC, NE, NJ, NM, NY, OH, OK, SC, SD, TN, TX, VA, WA, WY.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-1595-2021, Z-1596-2021

Terminated Class II Medical devices

Recall started
6 January 2021
Terminated
28 February 2024
Reason
May display Calcium results on the screen with wrong arrow direction which may lead to misinterpretation of results and incorrect medical decision. If the unit for iCa++ is set to mg/dL (configured as Service Code MGL) and a measured iCa++ value is lower than the normal range, an upward arrow is shown on the display instead of a downward arrow. The display is set per default to mmol/L; therefore, the arrow indicating an alarm reflects normal ranges of iCa++ in mmol/L. If mg/dL is chosen, the arrow warnings on screen still reflect the ranges from mmol/L, rather than mg/dL. The numeric result is displayed correctly.
Distribution
US Nationwide distribution.
Initiated
Voluntary: Firm initiated
Recall number
Z-1098-2021

Terminated Class II Medical devices

Recall started
17 December 2020
Terminated
19 May 2023
Reason
A software error results in the unintentional removal of the serum-indices flag that would otherwise prevent the release of results. The Cobas Inifinity has an auto-verification feature to hold results for manual review when they meet specific criteria. The serum indices flag is used for serum indices tests that are performed to assess the quality of the sample (e.g. hemolysis, icterus, and lipemia). Normally, when the Cobas Infinity receives a result for a test that is serum indices-sensitive, it flags the result and the software then waits for the results of the serum indices tests before validating or rejecting the test result. Roche has discovered a software error that under specific conditions causes the flag to be incorrectly removed. This allows for the possibility that a sample of poor quality may return an unreliable/incorrect test result that is mistakenly reported to the health care provider and/or patient without the proper disclaimer that the result is based on a sample of poor quality.
Distribution
US Nationwide
Initiated
Voluntary: Firm initiated
Recall number
Z-0883-2021

Ongoing Class II Medical devices

Recall started
8 December 2020
Reason
Potential for Changed Configuration Settings on the cobas 8000 modular analyzer series/cobas pro integrated solutions, may cause incorrect results in several affected parameters. In the case of poor sample quality, discrepant results may remain undetected due to the absence of associated data flags.
Distribution
US Nationwide distribution.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-0755-2021, Z-0754-2021

Terminated Class II Medical devices

Recall started
2 December 2020
Terminated
30 June 2022
Reason
Possible Misinterpretation of Displayed Measuring Units from INR to %Quick or Seconds; providing instructions to users for ensuring the meter is displaying INR results
Distribution
US Nationwide
Initiated
Voluntary: Firm initiated
Recall numbers
Z-0804-2021, Z-0803-2021

Terminated Class II Medical devices

Recall started
23 November 2020
Terminated
6 July 2023
Reason
During the subsequent pipetting (1st or 2nd measurement), the residual reagent can sporadically be transferred from the conus into the reaction cuvette and lead to inaccurately low results for the affected TDMs (Therapeutic Drug Monitoring).
Distribution
Domestic: IL, FL, GA, WV
Initiated
Voluntary: Firm initiated
Recall number
Z-0752-2021

Terminated Class II Medical devices

Recall started
6 November 2020
Terminated
18 October 2024
Reason
Roche confirmed customer complaints of low quality (QC) recovery and invalid calibrations for the Tina-quant C-Reactive Protein Gen. 3 on the cobas c701 and 702 modules. A discoloration (yellow color) was observed and is the result of cross contamination between the R1 and R3 reagents.
Distribution
US Nationwide distribution including in the states of AL, CA, FL, GA, HI, IA, IL, IN, KY, MA, MD, MI, MN, MO, NJ, NY, OH, PA, SC, TN, TX, VA.
Initiated
Voluntary: Firm initiated
Recall number
Z-0634-2021

Terminated Class II Medical devices

Recall started
9 October 2020
Terminated
9 June 2023
Reason
Potential Incorrect Validation of Results Due to an Erroneous QC Status When Using Status Expiration Control Rule
Distribution
Nationwide
Initiated
Voluntary: Firm initiated
Recall number
Z-0461-2021

Ongoing Class II Medical devices

Recall started
31 August 2020
Reason
Potential for Fluid leaks within the instruments, creating an electrical short inside the power socket, which generates heat, smoke, and eventually burning and melting of the electrical cord connector and socket
Distribution
Nationwide Foreign: Canada, Austria, Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Netherlands, Norway, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden, Switzerland, Tur
Initiated
Voluntary: Firm initiated
Recall numbers
Z-0086-2021, Z-0085-2021

Terminated Class III Medical devices

Recall started
27 August 2020
Terminated
22 May 2024
Reason
Roche has confirmed customer complaints of low quality (QC) recovery and invalid calibrations for the identified products. A discoloration (yellow color) was observed and is the result of cross contamination between the R1 and R3 reagents.
Distribution
Domestic distribution nationwide.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-0104-2021, Z-0103-2021

Terminated Class II Medical devices

Recall started
20 August 2020
Terminated
22 October 2021
Reason
Recent internal verification studies found the current RF interference claim to no longer be met for the assay on the cobas e 411, 601, and 602 analyzers. Therefore, the claim has been updated.
Distribution
US Nationwide
Initiated
Voluntary: Firm initiated
Recall number
Z-2981-2020

Terminated Class II Medical devices

Recall started
7 February 2020
Terminated
30 May 2024
Reason
The firm has received an increased number of complaints concerning non-reproducible elevated results ("high flyers") for one lot of Elecsys CA 19-9 reagent, which may affect clinical interpretation.
Distribution
US Nationwide distribution in the states of AL, AZ, CA, CO, FL, HI, IL, IN, KS, KY, MA, ME, MI, NC, NH, NJ, NY, TN, TX, WA and WI.
Initiated
Voluntary: Firm initiated
Recall number
Z-1444-2020

Terminated Class II Medical devices

Recall started
7 January 2020
Terminated
15 October 2020
Reason
Alarm flags that have a "<" symbol in front of them are not displayed on the cobas infinity Validation screen. This issue affects only customers that are doing manual validation on the cobas infinity Validation screen.
Distribution
Distributed to customers in AK, AL, CA, GA, HI, IA, IL, KY, MA, MI, MN, MO, MS, MT, NJ, NY, OR, SC, and TN.
Initiated
Voluntary: Firm initiated
Recall number
Z-1158-2020

Terminated Class II Medical devices

Recall started
28 October 2019
Terminated
28 June 2022
Reason
Current software version of the Anti-HAV IgM APP-file (version 06.05-101) downloaded an erroneous Border Area setting, (1.0 1.00) instead of (0.90 1.10).
Distribution
US Nationwide distribution.
Initiated
Voluntary: Firm initiated
Recall number
Z-0669-2020

Terminated Class II Medical devices

Recall started
8 October 2019
Terminated
15 October 2020
Reason
Cobasinfinity laboratory solution Version 2.4.1 through Version 2.5.4 Using a CommServer Driver - Incorrect Alarm Mapping
Distribution
US Nationwide in the states of AL, CA, GA, IA, IL, KY, MI, MO, MT, NJ, NY, OR, TN
Initiated
Voluntary: Firm initiated
Recall number
Z-0922-2020

Terminated Class II Medical devices

Recall started
4 October 2019
Terminated
9 October 2020
Reason
Homocysteine Reagent, Calibration Failures and Quality Control Recovery Issues on cobas c 701 and 702 modules
Distribution
US Nationwide distribution in the states of NJ, HI, IA.
Initiated
Voluntary: Firm initiated
Recall number
Z-0679-2020

Terminated Class III Medical devices

Recall started
11 September 2019
Terminated
11 June 2024
Reason
Due to low Quality Control recovery and invalid Calibration.
Distribution
US Nationwide distribution including the states of AL, AZ, CA, CT, FL, GA, HI, IA, IL, IN, KY, LA, MA, MD, MI, MO, NE, NH, NJ, NY, OH, OK, PA, PR, RI, SC, TN, TX, UT, VA and WI. Updated as of 12/20/19 to include the following additional US states: CO.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-0152-2020, Z-0153-2020

Terminated Class II Medical devices

Recall started
28 August 2019
Terminated
2 October 2020
Reason
Tina-quant Soluble Transferrin Receptor (STFR) Assays Updated Claims for Rheumatoid Factors Interference
Distribution
Nationwide
Initiated
Voluntary: Firm initiated
Recall numbers
Z-0109-2020, Z-0108-2020

Terminated Class II Medical devices

Recall started
13 August 2019
Terminated
30 June 2022
Reason
AssayTips part of the AssayTip/AssayCup Tray Tips used on the cobas e 801 module- may have an Abnormal Internal Structure and lead to Incorrect patient results
Distribution
Nationwide
Initiated
Voluntary: Firm initiated
Recall number
Z-0044-2020

Terminated Class II Medical devices

Recall started
23 July 2019
Terminated
8 June 2020
Reason
Inaccurately Low Sample Results
Distribution
AK AL AR AZ CA CO CT DC DE FL GA GU HI IA ID IL IN KS KY LA MA MD ME MI MN MO MS MT NC ND NE NH NJ NM NV NY OH OK OR PA PR RI SC SD TN TX UT VA VT WA WI WV WY
Initiated
Voluntary: Firm initiated
Recall numbers
Z-0042-2020, Z-0043-2020

Terminated Class II Medical devices

Recall started
18 July 2019
Terminated
15 June 2020
Reason
Quality issue with high pressure solenoid valves may cause inaccurate results.
Distribution
State NY MT HI IN MD TX OH KS KY CA FL OR LA MO AK
Initiated
Voluntary: Firm initiated
Recall numbers
Z-2476-2019, Z-2478-2019, Z-2477-2019

Terminated Class II Medical devices

Recall started
16 July 2019
Terminated
30 April 2021
Reason
Performance issues with certain lots of the Elecsys Anti-CCP assay on the cobas e 411 analyzer; MODULAR ANALYTICS E 170 module; and cobas e 601, 602, and 801 modules with plasma samples.
Distribution
AZ CA FL HI IA IL IN KY LA MA MI MO MT NJ NY OK OR PA PR SC TX VA
Initiated
Voluntary: Firm initiated
Recall numbers
Z-2362-2019, Z-2361-2019

Terminated Class II Medical devices

Recall started
2 July 2019
Terminated
22 October 2021
Reason
The firm conducted internal investigations that confirmed customer complaints of quality control (QC) imprecision and calibration failures for the Tina-quant Myoglobin Gen.2 assay (catalog number 04580010190), lot number 349860 on the cobas c311 analyzer and cobas c501 and c502 modules due to a drop in signal in the reaction kinetics. This signal drop was traced to an adjacent cell mixing effect. Sample recovery is decreased as a consequence of the disturbance in reaction kinetics. The investigation found discrepancies of up to -30%. Calibration, QC, and patient samples can be affected. The following issues were reported: - Calibration failures; Dup.E error due to signal drop in reaction kinetics - Sporadic quality control (QC) imprecision. As a long-term solution, the firm will implement required extra wash cycles (EWCs) into the respective Special Wash Requirements method sheets for the cobas c 311 analyzer and cobas c 501 and 502 modules, and into the cobas e-file for the cobas c 502 module. For the use of the reagent with the cobas c501 and c502, Roche will also direct users to run the Tina-Quant Myoglobin gen. 2 assay independently from other tests, in a batch mode status, with a maximum of 39 samples per run. Additionally, a change in the application settings of the Tina-quant Myoglobin Gen.2 assay on the cobas c 501 and 502 modules will be implemented so that adjacent cuvettes are no longer used in order to prevent adjacent cell mixing effects. The application settings change will be communicated at a later date.
Distribution
Nationwide
Initiated
Voluntary: Firm initiated
Recall number
Z-2445-2019

A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.